Implantable cardioverter-defibrillators in cardiac amyloidosis: a grey zone requiring an individual approach.

Implantable cardioverter-defibrillators in cardiac amyloidosis: a grey zone requiring an individual approach. Kardiol Pol. 2020 Jun 18;: Authors: Sławiński G, Dorniak K, Lewicka E PMID: 32550732 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32550732?dopt=Abstract

Source: Polish Heart Journal - June 17, 2020 Category: Cardiology Authors: Sławiński G, Dorniak K, Lewicka E Tags: Kardiol Pol Source Type: research

More News: Amyloidosis | Cardiology | Heart | Poland Health